Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis

Author:

Simons G1ORCID,Schölin Bywall K2ORCID,Englbrecht M34ORCID,Johansson EC5,DiSantostefano RL6ORCID,Radawski C7ORCID,Veldwijk J89ORCID,Raza K11011ORCID,Falahee M1ORCID

Affiliation:

1. Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK

2. Centre for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden

3. Freelance Healthcare Data Scientist, Eckental, Germany

4. Department of Internal Medicine and Institute for Clinical Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

5. Patient Research Partner, Swedish Rheumatism Association, Stockholm, Sweden

6. Janssen Research & Development, Titusville, NJ, USA

7. Eli Lilly and Company, Indianapolis, IN, USA

8. Erasmus School of Health Policy & Management and Erasmus Choice Modelling Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands

9. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

10. Department of Rheumatology, Sandwell and West Birmingham NHS Trust, Birmingham, UK

11. MRC Versus Arthritis Centre for Musculoskeletal Ageing Research and Research into Inflammatory Arthritis Centre Versus Arthritis, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3